In January 2022 Ginkgo Bioworks announced the acquisition of Project Beacon COVID-19 LLC (Project Beacon), a Boston-based social benefit organization focused on helping to increase the capacity, availability, accessibility and affordability of COVID-19 testing. Ginkgo acquired Project Beacon's assets and assumed responsibility for Project Beacon's ongoing operations and provided COVID-19 monitoring tools to communities in Massachusetts and other areas.
With this acquisition, Concentric integrated Project Beacon's partner and customer relationships, digital platform, and several key personnel into its broader efforts. As of June 2023 Project Beacon shut down its operations and any questions can be sent to help@beacontesting.com.